Platelet Rich Plasma (PRP) in Chronic Epicondylitis

PHASE3CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 1, 2018

Study Completion Date

July 1, 2018

Conditions
Epicondylitis
Interventions
DRUG

US-guided tenotomy with PRP

"Blood will be drawn from the patient from the patient's unaffected arm. the anti-coagulated blood will be centrifuged and pure-PRP (without leukocytes) collected.~Local anesthetic (lidocaine) will be infiltrated into the subcutaneous tissue of the lateral elbow, after which a single skin portal and multiple longitudinal and transversal penetrations of the tendon will be performed; PRP will be delivered in multiple depots during the procedure"

DRUG

US-guided tenotomy with lidocaine

Blood will be drawn from the patient from the patient's unaffected arm. Local anesthetic (lidocaine) will be infiltrated into the subcutaneous tissue of the lateral elbow, after which a single skin portal and multiple longitudinal and transversal penetrations of the tendon will be performed; lidocaine will be delivered in multiple depots during the procedure

Trial Locations (2)

48903

Cruces University Hospital/BioCruces Health Research Institute, Barakaldo

Cruces University Hospital, Barakaldo

All Listed Sponsors
lead

Jose Ignacio Martin

OTHER_GOV

NCT01945528 - Platelet Rich Plasma (PRP) in Chronic Epicondylitis | Biotech Hunter | Biotech Hunter